4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

Martin Birch, Alan; Woolf Goldberg, Frederick; Andrew Leach

4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

Martin Birch, Alan (Inventor), Woolf Goldberg, Frederick (Inventor), Andrew Leach (Inventor)

Pharmacy

Research output: Patent

Abstract

DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

Original language	English
Patent number	WO2011121350
IPC	A61P 3/ 10 A I
Priority date	27/07/10
Publication status	Published - 6 Oct 2011

Cite this

@misc{b5c88d31c6474290b810dc08359276cf,

title = "4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS",

abstract = "DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.",

author = "{Birch, Alan}, Martin and {Goldberg, Frederick}, Woolf and Andrew Leach",

year = "2011",

month = oct,

day = "6",

language = "English",

type = "Patent",

note = "WO2011121350; A61P 3/ 10 A I",

}

TY - PAT

T1 - 4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

AU - Birch, Alan, Martin

AU - Goldberg, Frederick, Woolf

AU - Leach, Andrew

PY - 2011/10/6

Y1 - 2011/10/6

N2 - DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

AB - DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

M3 - Patent

M1 - WO2011121350

ER -

4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS

Abstract

Fingerprint

Cite this